Natividad Banaclocha-Martinez - Publications

Incidence and features of maculopapular rashes in patients receiving immune checkpoint inhibitors.

Journal: Anais brasileiros de dermatologia

Published: March 15, 2026

Plasmatic CXCL13 as a biomarker of primary resistance to immunotherapy and impaired peripheral immunity in non-small cell lung cancer.

Journal: Biomarker research

Published: January 09, 2026

Early pembrolizumab plasma levels as a prognostic biomarker in real-world NSCLC patients.

Journal: Pharmacological research

Published: December 02, 2025

Deep Learning Model-Based Architectures for Lung Tumor Mutation Profiling: A Systematic Review.

Journal: Cancers

Published: October 09, 2025

SEOM-GOTEL clinical guidelines on diffuse large B-cell lymphoma (update 2025).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: September 25, 2025

Triple M overlap syndrome following pembrolizumab treatment: importance of multidisciplinary approach.

Journal: BMJ case reports

Published: January 21, 2025

Vitiligo-like hypopigmentation secondary to adjuvant checkpoint inhibitor therapy in patients with resectable stage III melanoma: a cohort from two tertiary hospitals.

Journal: Melanoma research

Published: January 08, 2025

Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL Trial.

Journal: Cancers

Published: December 03, 2024

Efficacy and safety of lorlatinib in patients with ALK- and ROS1-rearranged metastatic non-small cell lung cancer treated within the compassionate use program in Spain.

Journal: Cancer treatment and research communications

Published: November 03, 2024

Association of Cutaneous Immune-related Adverse Events with Overall Survival and Progression-free Survival in Oncology Patients Receiving Immune Checkpoint Inhibitors: A Prospective Study of 189 Patients in a Spanish Tertiary Care Hospital.

Journal: Acta dermato-venereologica

Published: September 16, 2024

A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL).

Journal: Cancers

Published: February 12, 2024

Cutaneous immune-related adverse events: incidence rates, risk factors and association with extracutaneous toxicity - a prospective study of 189 patients treated with checkpoint inhibitors at a Spanish tertiary care hospital.

Journal: Clinical and experimental dermatology

Published: December 10, 2023